B. O'sullivan

发表

Cystic fibrosis

S. Freedman, B. O'sullivan, 2009, The Lancet.

Chapter 7 Platelets , Inflammation and Respiratory Disease

B. O'sullivan, S. Kerrigan, 2018 .

Platelets, Inflammation and Respiratory Disease

B. O'sullivan, S. Kerrigan, 2015 .

The inflammatory role of platelets in cystic fibrosis.

A. Michelson, B. O'sullivan, 2006, American journal of respiratory and critical care medicine.

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

Karen A Robinson, C. Goss, K. Robinson, 2007, American journal of respiratory and critical care medicine.

Inhaled aztreonam

P. Kirkpatrick, B. O'sullivan, Uma Yasothan, 2010, Nature Reviews Drug Discovery.

The clinical approach to lung disease in patients with cystic fibrosis.

P. Flume, B. O'sullivan, 2009, Seminars in respiratory and critical care medicine.

Importance of Off-Label Options for Treating Serious Lung Diseases.

B. O'sullivan, 2016, Annals of the American Thoracic Society.

CHAPTER 12 – Interstitial Lung Diseases

B. O'sullivan, 2005 .

Infection control in cystic fibrosis: share and share alike

C. Sassetti, B. O'sullivan, 2013, The Lancet.

Tracheal bronchus: a cause of prolonged atelectasis in intubated children.

J. Frassica, B. O'sullivan, S. Rayder, 1998, Chest.

Assessment of repeatability of hyperpolarized gas MR ventilation functional imaging in cystic fibrosis.

J. P. Roche, M. Botfield, B. O'sullivan, 2014, Academic radiology.

Pulmonary Manifestations of Systemic Vasculitis

B. O'sullivan, Ted M. Kremer, 2009 .

Survey of breast‐feeding practices and outcomes in the cystic fibrosis population

M. Regan, S. Freedman, B. O'sullivan, 2004, Pediatric pulmonology.

Pricing for orphan drugs: will the market bear what society cannot?

D. Orenstein, C. Milla, B. O'sullivan, 2013, JAMA.

Comparison of Nasal Potential Difference and Intestinal Current Measurements as Surrogate Markers for CFTR Function

S. Freedman, E. Kerem, S. Sheth, 2016, Journal of pediatric gastroenterology and nutrition.

Oropharyngeal flora in healthy infants: Observations and implications for cystic fibrosis care

R. Parad, B. O'sullivan, A. Comeau, 2009, Pediatric pulmonology.

Reduction of eicosanoid production by essential fatty acid depletion does not attenuate the inflammatory response induced by Pseudomonas aeruginosa pneumonia in rat lung.

D. Schidlow, B. O'sullivan, B. Votta, 1992, Prostaglandins, leukotrienes, and essential fatty acids.

J. Lang, B. O'sullivan, L. James, 2020, Pediatric pulmonology.

Raising new questions on best care for bronchiectasis.

B. O'sullivan, 2019, The Lancet. Respiratory medicine.

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm

R. Parad, H. Dorkin, R. Gerstle, 2010, Journal of Inherited Metabolic Disease.

A fifteen-year-old boy with eosinophilia and pulmonary infiltrates.

K. Nimkin, B. O'sullivan, D. L. Gang, 1993, The Journal of pediatrics.

A fifteen-year-old boy with and pulmonary infiltrates eosinophilia

K. Nimkin, B. O'sullivan, D. L. Gang, 1993 .

Pulmonary complications of systemic vasculitides.

B. O'sullivan, 2012, Paediatric respiratory reviews.

Mini-Symposium: Pulmonary Complications of Paediatric Systemic Disorders Pulmonary Complications of Systemic Vasculitides

B. O'sullivan, 2012 .

aminoglycoside-based suppression of PTCs is exciting, but much is left to be done.

B. O'sullivan, 2014 .

Prior exposure to endotoxin exacerbates lipopolysaccharide-induced hypoxemia and alveolitis in anesthetized swine.

R. Allen, B. O'sullivan, M. Menconi, 1994, Shock.

Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis.

S. Freedman, M. Laposata, B. O'sullivan, 2007, Clinical chemistry.

Early Pulmonary Manifestation of Cystic Fibrosis in Children With the ΔF508/R117H-7T Genotype

R. Parad, H. Dorkin, B. O'sullivan, 2006, Pediatrics.

Evolution of pancreatic function during the first year in infants with cystic fibrosis.

S. Baker, K. Leung, B. O'sullivan, 2013, The Journal of pediatrics.

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-2002. An eight-year-old girl with fever, hemoptysis, and pulmonary consolidations.

L. Erickson, B. O'sullivan, J. Niles, 2002, The New England journal of medicine.

Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result.

R. Parad, H. Dorkin, K. Haver, 2005, The Journal of pediatrics.

Challenges in implementing a successful newborn cystic fibrosis screening program.

R. Parad, H. Dorkin, K. Haver, 2005, The Journal of pediatrics.

Cystic fibrosis pulmonary guidelines: airway clearance therapies.

K. Robinson, P. Flume, J. Finder, 2009, Respiratory care.

Treatment of bronchiolitis.

B. O'sullivan, R. Zwerdling, 2003, The New England journal of medicine.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

Kapil M. Patel, D. Sanders, R. Gibson, 2022, The Lancet. Respiratory medicine.

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. II. Transfection efficiency in airway epithelium.

J. Morris, K. Pavelka, Alan E. Smith, 2001, Human gene therapy.

Cystic fibrosis heterozygotes do not have increased platelet activation.

A. Michelson, A. Frelinger, M. Barnard, 2007, Thrombosis research.

By the sweat of our brows: how salty should a person be?

B. O'sullivan, R. Zwerdling, 2008, The Journal of pediatrics.

Empyema in a Woman with Cystic Fibrosis: A Cautionary Tale

B. O'sullivan, O. Schaefer, K. Uy, 2013, Case reports in pulmonology.

The use of aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in children with leukemia

B. O'sullivan, R. Spaulding, Rhoda Spaulding, 1994, Pediatric pulmonology.

Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report

M. Rosenfeld, B. Wilfond, R. Parad, 2007, Pediatrics.

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

R. Parad, D. Waltz, H. Dorkin, 2004, Pediatrics.

Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs.

M. Fink, B. O'sullivan, M. Menconi, 1993, The Journal of trauma.

Nonbronchoscopic approach to bronchoalveolar lavage in children with artificial airways

B. O'sullivan, H. Panitch, B. Alpert, 1992, Pediatric pulmonology.

Burkholderia pseudomallei infection in a child with cystic fibrosis: acquisition in the Western Hemisphere.

Theresa L. Smith, J. Gee, S. Smole, 2011, Chest.

Localized pneumothorax with lobar collapse and diffuse obstructive airway disease

K. Nimkin, B. O'sullivan, M. Spevak, 1995, Pediatric Radiology.

Use of nasopharyngoscopy in the evaluation of children with noisy breathing.

B. O'sullivan, R. Zwerdling, L. Finger, 2004, Chest.

Platelet activation in cystic fibrosis.

James E. Morris, A. Michelson, M. Laposata, 2005, Blood.

Interleukin 8 Secretion from Monocytes of Subjects Heterozygous for the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Is Altered

M. Regan, S. Freedman, A. Gelrud, 2004, Clinical Diagnostic Laboratory Immunology.

Targeting nonsense-mediated cystic fibrosis: is it premature to stop now?

B. O'sullivan, 2014, The Lancet. Respiratory medicine.

Intensive Care Management of the Patient With Cystic Fibrosis

B. O'sullivan, P. Michelson, Ted M. Kremer, 2008, Journal of intensive care medicine.

How many billions is enough? Prioritizing profits over patients with cystic fibrosis

G. Sawicki, M. McGarry, B. O'sullivan, 2023, Pediatric pulmonology.

Interleukin 8 Secretion from Monocytes of Subjects Heterozygous for the ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Is Altered

M. Regan, S. Freedman, A. Gelrud, 2004, Clinical Diagnostic Laboratory Immunology.

LY255283, a novel leukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs.

M. Fink, B. O'sullivan, M. Menconi, 1993, Surgery.

Acute lung injury in endotoxemic pigs: role of leukotriene B4.

B. O'sullivan, M. Menconi, V. Larkin, 1995, Journal of applied physiology.

Association of cystic fibrosis with abnormalities in fatty acid metabolism.

M. Regan, S. Freedman, M. Laposata, 2004, The New England journal of medicine.

Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia.

B. O'sullivan, R. Kradin, M. Menconi, 1994, Journal of applied physiology.

Using hyperpolarized 3He MRI to evaluate treatment efficacy in cystic fibrosis patients

Austin Reno, Yanping Sun, John P Roche, 2011, Journal of magnetic resonance imaging : JMRI.

A novel leukotriene B4-receptor antagonist in endotoxin shock: A prospective, controlled trial in a porcine model

M. Fink, B. O'sullivan, J. Fleisch, 1993, Critical care medicine.

Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.

J. S. St. George, H. Dorkin, M. Perricone, 2001, Human gene therapy.

Platelet activation in cysticfibrosis

A. Michelson, M. Laposata, A. Frelinger, 2013 .

Cystic Fibrosis: Breakthrough Drugs at Break-the-Bank Prices

P. Quinton, D. Orenstein, B. O'sullivan, 2015, Global advances in health and medicine.

The clinical approach to lung disease in patients with cystic fibrosis.

P. Flume, B. O'sullivan, 2009, Seminars in respiratory and critical care medicine.

Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.

B. O'sullivan, S. Mong, 1989, Molecular pharmacology.

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

C. Goss, K. Robinson, P. Flume, 2007, American journal of respiratory and critical care medicine.

By the sweat of our brows: how salty should a person be?

B. O'sullivan, R. Zwerdling, 2008, The Journal of pediatrics.

Using hyperpolarized 3He MRI to evaluate treatment efficacy in cystic fibrosis patients

J. P. Roche, B. O'sullivan, M. Albert, 2011, Journal of magnetic resonance imaging : JMRI.

Sweat testing infants detected by cystic fibrosis newborn screening.

R. Parad, H. Dorkin, R. Gerstle, 2005, The Journal of pediatrics.

Protocol for the Vitamin D Oral Replacement in Asthma (VDORA) study.

F. Prior, B. O'sullivan, J. Snowden, 2022, Contemporary clinical trials.

Pricing for orphan drugs: will the market bear what society cannot?

D. Orenstein, C. Milla, B. O'sullivan, 2013, JAMA.